Litcius/Paper detail

SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene

Youwei Zhu, Zhaoyang Zhang, Jia Song, Weizhou Qian, Gu Xiangqian, Chaoyong Yang, Nan Shen, Feng Xue, Yuanjia Tang

2021Frontiers in Immunology28 citationsDOIOpen Access PDF

Abstract

Infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the rapid spread of coronavirus disease 2019 (COVID-19), has generated a public health crisis worldwide. The molecular mechanisms of SARS-CoV-2 infection and virus-host interactions are still unclear. In this study, we identified four unique microRNA-like small RNAs encoded by SARS-CoV-2. SCV2-miR-ORF1ab-1-3p and SCV2-miR-ORF1ab-2-5p play an important role in evasion of type I interferon response through targeting several genes in type I interferon signaling pathway. Particularly worth mentioning is that highly expressed SCV2-miR-ORF1ab-2-5p inhibits some key genes in the host innate immune response, such as IRF7, IRF9, STAT2, OAS1, and OAS2. SCV2-miR-ORF1ab-2-5p has also been found to mediate allelic differential expression of COVID-19-susceptible gene OAS1. In conclusion, these results suggest that SARS-CoV-2 uses its miRNAs to evade the type I interferon response and links the functional viral sequence to the susceptible genetic background of the host.

Topics & Concepts

InterferonIRF7BiologyGenemicroRNAInnate immune systemCoronavirusSTAT2GeneticsInterferon type IAlleleVirologyRegulation of gene expressionInterferon-stimulated geneImmune systemVirusGene expressionDiseaseMedicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)STAT3PathologystatSARS-CoV-2 and COVID-19 Researchinterferon and immune responsesMicroRNA in disease regulation
SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene | Litcius